ArticleFrontiers in oncology2024
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of
Evan DuBose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleFrontiers in oncology2024
Evan DuBose et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.